Nac 600 Akut 1 A Pharma (Acetylcysteine)

Acetylcysteine, the active ingredient in Nac 600 Akut 1 A Pharma, is a mucolytic presented as a 600 mg oral dosage form for oral use. It reduces the viscosity of respiratory mucus and is employed in the management of chronic bronchitis, acute respiratory tract infections, and cystic fibrosis.

GNH USA supplies Nac 600 Akut 1 A Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to EU and other markets.

Acetylcysteine is used as a mucolytic agent in several respiratory conditions. - Chronic bronchitis: improves mucus clearance and reduces cough frequency. - Acute respiratory tract infections: thins secretions to facilitate expectoration. - Cystic fibrosis: helps prevent accumulation of thick mucus in the airways. - Chronic obstructive pulmonary disease (COPD): aids in sputum expectoration. - Post‑operative pulmonary care: reduces risk of mucus retention.

Acetylcysteine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional emesis. - Diarrhea: loose stools. - Abdominal pain: cramp‑like discomfort. - Rash: mild skin irritation. - Metallic taste: transient after ingestion.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with airway compromise. - Stevens‑Johnson syndrome: serious skin and mucous membrane disorder. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Neutropenia: reduced white blood cell count. - Bronchospasm: worsening airway constriction. - Severe skin reactions: toxic epidermal necrolysis.

When using acetylcysteine, several precautions should be observed to ensure safe therapy. - Renal function assessment: adjust use in patients with impaired kidney function. - Hepatic monitoring: watch for signs of liver injury during prolonged therapy. - Asthma caution: avoid in patients with a history of bronchospasm triggered by the drug. - Hypersensitivity screening: discontinue if allergic reactions occur. - Concomitant medication review: evaluate potential interactions before initiating therapy. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Acetylcysteine can interact with other medicines, influencing their effectiveness or safety.

Major Interactions (Avoid): - Nitroglycerin: may potentiate hypotensive effects. - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Chemotherapy agents (e.g., cyclophosphamide): may reduce antineoplastic efficacy.

Moderate Interactions (Monitor Closely): - Antipsychotics (e.g., haloperidol): possible enhancement of sedation. - Oral contraceptives: may decrease hormonal effectiveness. - ACE inhibitors: monitor blood pressure for additive effects. - Antihistamines: potential alteration of mucolytic activity.